IL-17A produced by both γδ T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction

Journal of Pathology

Volumn 235, Issue 1, 2015, Pages 79-89

  Peng, Xiaogang ^a   Xiao, Zhicheng ^a   Zhang, Jing ^a   Li, Yulin ^a   Dong, Yanjun ^a   Du, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

IL 17A; Inflammation; Obstructive nephropathy; RANTES; Renal fibrosis

Indexed keywords

CD4 ANTIGEN; COLLAGEN; INTERLEUKIN 17; NEUTRALIZING ANTIBODY; RANTES; CCL5 PROTEIN, MOUSE; CHEMOKINE; IL17A PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; GAMMA DELTA T LYMPHOCYTE; INFLAMMATION; KIDNEY FIBROSIS; LEUKOCYTE; MACROPHAGE; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; TH17 CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; FIBROSIS; GENETICS; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CHEMOKINE CCL5; CHEMOKINES; FIBROSIS; INFLAMMATION; INTERLEUKIN-17; KIDNEY; KIDNEY DISEASES; LEUKOCYTES; MACROPHAGES; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TH17 CELLS;

EID: 84916594213     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4430     Document Type: Article

References (56)

1. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684-696.
2. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
3. Grande MT, Perez-Barriocanal F, Lopez-Novoa JM. Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy. J Inflam 2010; 7: 19.
4. Eddy AA. Progression in chronic kidney disease. Adv Chron Kidney Dis 2005; 12: 353-365.
5. Meldrum KK, Metcalfe P, Leslie JA, et al. TNF-α neutralization decreases nuclear factor-κB activation and apoptosis during renal obstruction. J Surg Res 2006; 131: 182-188.
6. Wada T, Furuichi K, Sakai N, et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004; 15: 940-948.
7. Vielhauer V, Kulkarni O, Reichel CA, et al. Targeting the recruitment of monocytes and macrophages in renal disease. Semin Nephrol 2010; 30: 318-333.
8. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522-3530.
9. Duffield JS. Macrophages and immunologic inflammation of the kidney. Semin Nephrol 2010; 30: 234-254.
10. Lin SL, Castano AP, Nowlin BT, et al. Bone marrow Ly6C high monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009; 183: 6733-6743.
11. Wang Y, Harris DC. Macrophages in renal disease. J Am Soc Nephrol 2011; 22: 21-27.
12. + T cells: a potential player in renal fibrosis. Kidney Int 2010; 78: 333-335.
13. + T cells in renal fibrosis following ureteric obstruction. Kidney Int 2010; 78: 351-362.
14. + T lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis. Am J Nephrol 2012; 36: 386-396.
15. + monocytes into fibrocytes. Proc Natl Acad Sci USA 2009; 106: 17892-17897.
16. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.
17. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-467.
18. Hasan SA, Eksteen B, Reid D, et al. Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis. J Allergy Clin Immunol 2013; 131: 1663-1673.
19. Hara M, Kono H, Furuya S, et al. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. J Surg Res 2013; 183: 574-582.
20. Tan Z, Qian X, Jiang R, et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 2013; 191: 1835-1844.
21. Wilson MS, Madala SK, Ramalingam TR, et al. Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 2010; 207: 535-552.
22. Turner JE, Krebs C, Tittel AP, et al. IL-17A production by renal γδT cells promotes kidney injury in crescentic GN. J Am Soc Nephrol 2012; 23: 1486-1495.
23. Li L, Huang L, Vergis AL, et al. IL-17 produced by neutrophils regulates IFN-γ-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010; 120: 331-342.
24. Zhao N, Hao J, Ni Y, et al. Vγ4γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J Immunol 2011; 187: 5007-5014.
25. Yang J, Shultz RW, Mars WM, et al. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 2002; 110: 1525-1538.
26. Lionakis MS, Lim JK, Lee CC, et al. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun 2011; 3: 180-199.
27. Chen G, Lin SC, Chen J, et al. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol 2011; 22: 1876-1886.
28. Cheng J, Du J. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor. Arterioscler Thromb Vasc Biol 2007; 27: 1744-1751.
29. Yang M, Zheng J, Miao Y, et al. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol 2012; 32: 1675-1686.
30. Montecucco F, Braunersreuther V, Lenglet S, et al. CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. Eur Heart J 2012; 33: 1964-1974.
31. +T helper cells. Cell 2006; 126: 1121-1133.
32. Segerer S, Schlondorff D. Role of chemokines for the localization of leukocyte subsets in the kidney. Semin Nephrol 2007; 27: 260-274.
33. Gaffen SL. Recent advances in the IL-17 cytokine family. Curr Opin Immunol 2011; 23: 613-619.
34. Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112: 1486-1494.
35. Yang J, Chen J, Yan J, et al. Effect of interleukin 6 deficiency on renal interstitial fibrosis. PloS One 2012; 7: e52415.
36. Pindjakova J, Hanley SA, Duffy MM, et al. Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction. Kidney Int 2012; 81: 379-390.
37. +T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 2013; 123: 247-260.
38. Lo Re S, Dumoutier L, Couillin I, et al. IL-17A-producing γδ T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol 2010; 184: 6367-6377.
39. Sutton CE, Lalor SJ, Sweeney CM, et al. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 2009; 31: 331-341.
40. Cai Y, Shen X, Ding C, et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 2011; 35: 596-610.
41. Vernon MA, Mylonas KJ, Hughes J. Macrophages and renal fibrosis. Semin Nephrol 2010; 30: 302-317.
42. Henderson NC, Mackinnon AC, Farnworth SL, et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 2008; 172: 288-298.
43. Ge S, Hertel B, Susnik N, et al. Interleukin 17 receptor A modulates monocyte subsets and macrophage generation in vivo. PloS One 2014; 9: e85461.
44. Krebs CF, Lange S, Niemann G, et al. Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate + angiotensin ii-induced hypertension. Hypertension 2014; 63: 565-571.
45. Panzer U, Steinmetz OM, Stahl RA, et al. Kidney diseases and chemokines. Curr Drug Targets 2006; 7: 65-80.
46. Vielhauer V, Anders HJ, Mack M, et al. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 2001; 12: 1173-1187.
47. Krensky AM, Ahn YT. Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol 2007; 3: 164-170.
48. Li Y, Wen X, Liu Y. Tubular cell dedifferentiation and peritubular inflammation are coupled by the transcription regulator Id1 in renal fibrogenesis. Kidney Int 2012; 81: 880-891.
49. Kramer JM, Yi L, Shen F, et al. Evidence for ligand-independent multimerization of the IL-17 receptor. J Immunol 2006; 176: 711-715.
50. Ishigame H, Kakuta S, Nagai T, et al. Differential roles of interleukin-17A and -17 F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009; 30: 108-119.
51. Kuestner RE, Taft DW, Haran A, et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17 F. J Immunol 2007; 179: 5462-5473.
52. Turner JE, Paust HJ, Steinmetz OM, et al. The Th17 immune response in renal inflammation. Kidney Int 2010; 77: 1070-1075.
53. Van Kooten C, Boonstra JG, Paape ME, et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998; 9: 1526-1534.
54. Paust HJ, Turner JE, Steinmetz OM, et al. The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol 2009; 20: 969-979.
55. Kitagawa K, Wada T, Furuichi K, et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004; 165: 237-246.
56. Nakaya I, Wada T, Furuichi K, et al. Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. Nephron Exp Nephrol 2007; 107: e12-21.